The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Puentes, S. M.
Right arrow Articles by Joiner, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Puentes, S. M.
Right arrow Articles by Joiner, K. A.

The Journal of Immunology, Vol 145, Issue 12 4311-4316, Copyright © 1990 by American Association of Immunologists

ARTICLES

Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9

SM Puentes, RP Da Silva, DL Sacks, CH Hammer and KA Joiner
Laboratory of Parasitic Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, MD 20892.

The mechanism of serum resistance for infective promastigotes of Leishmania major was investigated. Prior results suggested that the mechanism of resistance was mediated at a step after C3 deposition. Equivalent amounts of C3b were deposited on serum-susceptible, noninfective promastigotes harvested from log stage cultures (LOG) and on C-resistant, infective, metacyclic promastigotes (MP) purified from stationary stage cultures. Whereas binding of C9 to LOG was stable during incubation in serum, C9 binding to MP was minimal and unstable, because molecules bound initially to MP were released with continued incubation. Failure to bind C9 was not a result of inability to activate C; the kinetics of C3, C6, and C9 consumption were similar for LOG and MP. Deposition of C5b-7 on MP was stable, indicating that the initial steps in terminal complex formation were intact. Instead, the majority of C5b-9 formed on MP was spontaneously released into the serum as SC5b-9. Residual C5b-9 on MP was released with 1 M NaCl. These data show that developmental modification of the promastigote membrane during transition from a noninfective to an infective stage blocks insertion of lytic C5b-9 into the promastigote membrane.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Colmenares, A. L. Corbi, S. J. Turco, and L. Rivas
The Dendritic Cell Receptor DC-SIGN Discriminates among Species and Life Cycle Forms of Leishmania
J. Immunol., January 15, 2004; 172(2): 1186 - 1190.
[Abstract] [Full Text] [PDF]

Home page
 Microbiol. Mol. Biol. Rev.Home page
M. J. McConville, K. A. Mullin, S. C. Ilgoutz, and R. D. Teasdale
Secretory Pathway of Trypanosomatid Parasites
Microbiol. Mol. Biol. Rev., March 1, 2002; 66(1): 122 - 154.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
M. L. Cunningham, R. G. Titus, S. J. Turco, and S. M. Beverley
Regulation of Differentiation to the Infective Stage of the Protozoan Parasite Leishmania major by Tetrahydrobiopterin
Science, April 13, 2001; 292(5515): 285 - 287.
[Abstract] [Full Text]

Home page
 J. Cell Sci.Home page
J Alexander, A. Satoskar, and D. Russell
Leishmania species: models of intracellular parasitism
J. Cell Sci., January 9, 1999; 112(18): 2993 - 3002.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
G Winter, M Fuchs, M. McConville, Y. Stierhof, and P Overath
Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid
J. Cell Sci., January 9, 1994; 107(9): 2471 - 2482.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.